Skip to main content

Table 2 Multivariate analysis of correlation between phosphorylation of transgelin-2 at S145 residue and clinicopathologocial factors

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variable Odds Ratio (95%) CI p value
Tumor Stage (III-IV) 1.983 (0.671–5.994) 0.215
Lymph Node Involvement (yes) 1.601 (0.535–4.672) 0.393
Tumor Size (≥2 cm) 3.153 (1.363–7.636) 0.009